01 1Taro Pharmaceutical Industries
01 1DEFERIPRONE
01 1U.S.A
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2015-06-09
Pay. Date : 2015-03-31
DMF Number : 28983
Submission : 2015-03-30
Status : Active
Type : II
20
Taro Pharmaceutical Industries Ltd, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is DEFERIPRONE, with a corresponding US DMF Number 28983.
Remarkably, this DMF maintains an Active status since its submission on March 30, 2015, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of June 09, 2015, and payment made on March 31, 2015, indicating their dedication to facilitating drug approvals, Categorized as Type II
